PAPER
Total Synthesis of the Proposed Structure of Montiporyne E
IR (film): 1680, 1520, 1260 cm–1.
2321
Table 1 Comparisons of the 1H and 13C NMR Data for the Synthetic
and Natural Sample of 1
1H NMR (400 MHz, CDCl3): d = 7.25 (d J = 8.7 Hz, 2 H), 6.86 (d,
J = 8.7 Hz, 2 H), 5.15 (s, 1 H), 4.61 (s, 2 H), 3.81 (s, 3 H), 3.80 (q,
J = 7.0 Hz, 2 H), 3.31 (dd, J = 7.4, 6.0 Hz, 2 H), 2.36 (t, J = 7.3 Hz,
2 H), 1.81–1.75 (m, 2 H), 1.34 (t, J = 7.0 Hz, 3 H).
13C NMR (100 MHz, CDCl3): d = 166.2, 159.3, 130.8, 129.9, 116.5,
114.3, 96.8, 63.9, 55.6, 50.4, 46.8, 31.1, 27.8, 14.7.
O
HN
3
7
5
LC/MS (APCI+): m/z = 276.0 (M + H).
HRMS (ESI): m/z calcd for C16H21O3N [M+]: 275.1516; found:
1
275.15201.
Position
1H 1
(ppm)
1H Natural
(ppm)
13C 1
(ppm)
13C Natural
(ppm)
N-(p-Methoxybenzyl)azepane-2,4-dione (10)
To a solution of 9 (231 mg, 0.8 mmol) in EtOH (3 mL), was added
H2O (3 mL) and concd HCl (1 mL). The mixture was heated to
50 °C for 2–3 h, then cooled to r.t. The mixture was poured into an
ice bath, neutralized with a 10% solution of K2CO3 (10 mL), and
then extracted with EtOAc (2 × 10 mL). The resulting organic lay-
ers were dried over MgSO4, filtered, and concentrated to give 10 as
a pure yellow oil (180 mg, 87%).
3
5
6
7
6.22
2.58
2.03
3.27
6.60
2.75
1.86
3.35
131.2
32.9
28.2
39.7
115.7
28.2
23.4
42.9
IR (film): 1700, 1650, 1520, 1250 cm–1.
1H NMR (400 MHz, CDCl3): d = 7.24 (d, J = 8.7 Hz, 2 H), 6.87 (d,
J = 8.7 Hz, 2 H), 4.59 (s, 2 H), 3.81 (s, 3 H), 3.61 (s, 2 H), 3.52 (t,
J = 6.0 Hz, 2 H), 2.54 (t, J = 7.1 Hz, 2 H), 1.79 (m, 2 H).
13C NMR (100 MHz, CDCl3): d = 203.5, 167.0, 159.2, 129.6 (2 C),
129.2, 114.1 (2 C), 55.2, 52.2, 50.1, 46.2, 41.6, 25.5.
All solvents were freshly distilled before use and anhyd THF and
Et2O were distilled under argon from Na/benzophenone. Chemical
1
shifts in H and 13C NMR spectra are reported relative to residual
solvents. Progress of the reactions were monitored by TLC using
Kodak silica gel 60 F254 pre-coated plates and visualized using UV
lamps or staining with a mixture of p-anisaldehyde/H2SO4/EtOH or
KMnO4/NaOH/K2CO3/H2O. The products were purified by column
chromatography (SiO2). Analytical data of all known compounds
were compared with the literature, and new compounds that were
stable were fully characterized.
HRMS (ESI): m/z calcd for C14H17O3NNa [M + Na]: 270.1101;
found: 270.1093.
Trifluoromethanesulfonic Acid N-(p-Methoxybenzyl)-2-
oxoazepan-4-yl Ester (2)
To a solution of 10 (146 mg, 0.6 mmol) in CH2Cl2 (4 mL) was added
an aq solution of NaOH (3 N, 4 mL), followed by the dropwise ad-
dition of Tf2O (0.2 mL, 1.2 mmol) at 0 °C. The resulting mixture
was slowly warmed to r.t. over 12 h. The mixture was diluted with
CH2Cl2 (10 mL) and the phases separated. The organic phase was
washed with H2O (15 mL) and brine (15 mL), dried over MgSO4,
filtered, and concentrated in vacuo. The residue was purified by col-
umn chromatography to give 2 as a colorless oil (133 mg, 60%).
1H NMR (400 MHz, CDCl3): d = 7.23 (d, J = 8.6 Hz, 2 H), 6.90 (d,
J = 8.6 Hz, 2 H), 6.19 (s, 1 H), 4.61 (s, 2 H), 3.82 (s, 3 H), 3.39 (m,
2 H), 2.65 (t, J = 7.1 Hz, 2 H), 1.89 (m, 2 H).
4-Ethoxy-1,5,6,7-tetrahydroazepin-2-one (8)
To a solution of syn-3-ethoxy-2-cyclohexen-1-one (5; 1.0g, 6.5
mmol) in anhyd THF (25 mL) was added Et3N (1.8 mL) at 0–5 °C,
followed by addition of p-TsCl (1.5 g, 7.8 mmol). After stirring for
an additional 1 h at this temperature, the reaction was quenched with
a 10% solution of K2CO3 (20 mL). After removal of the ice water
bath, the reaction mixture was allowed to warm to r.t. for 1 h. The
solvent was removed under reduced pressure, the residue was neu-
tralized with 1 N HCl and extracted with CH2Cl2 (2 × 15 mL). The
combined organic layers were washed with H2O (30 mL), brine (25
mL), dried over MgSO4, filtered, and concentrated in vacuo. The
residue was purified by flash chromatography to give the pure prod-
uct 8 as colorless needles (795 mg, 80%);7,11 mp 117–118 °C.
13C NMR (100 MHz, CDCl3): d = 164.0, 159.2, 156.9, 129.6 (2 C),
128.8, 118.8, 113.9 (2 C), 55.2, 50.7, 45.8, 43.4, 31.7, 26.3.
IR (film): 3260, 1680,1580 cm–1.
LC-MS (APCI+): m/z = 380.0 (M + H).
1H NMR (400 MHz, CDCl3): d = 6.08 (br s, 1 H), 5.11 (s, 1 H), 3.82
(q, J = 7.0 Hz, 2 H), 3.29–3.25 (m, 2 H), 2.52 (t, J = 7.0 Hz, 2 H),
2.0–1.96 (m, 2 H), 1.35 (t, J = 7.0 Hz, 3 H).
13C NMR (100 MHz, CDCl3): d = 172.9, 168.4, 97.0, 63.9, 41.4,
33.1, 27.4, 14.6.
N-(p-Methoxybenzyl)-4-undeca-1,3-diynyl-1,5,6,7-tetra-
hydroazepin-2-one (11)
To a solution of enol triflate 2 (29 mg, 0.08 mmol) and diacetylene
3 (13.6 mg, 0.09 mmol) in DMF (2 mL) was added CuI (2.9 mg, 0.2
mmol) and Pd(PPh3)2Cl2 (5.4 mg, 0.1 mmol), followed by the addi-
tion of Et3N (21.5 mL, 0.15 mmol) at r.t. The solution was stirred for
12 h and then diluted with Et2O (8 mL). The organic phase was
washed with a sat. solution of NaHCO3, a sat. solution of NH4Cl (10
mL), H2O (10 mL), and brine (15 mL), dried over MgSO4, filtered,
and concentrated in vacuo. The crude product was purified by col-
umn chromatography to afford 11 as a brown oil (26 mg, 90%).
LC-MS (APCI+): m/z = 156.1 (M + H), 311.0 (2 M + H).
4-Ethoxy-N-(p-methoxybenzyl)-1,5,6,7-tetrahydroazepin-2-one
(9)
To a solution of 8 (50 mg, 0.3 mmol) in anhyd DMF (1 mL), was
added NaH (60%; 15.4 mg, 0.4 mmol) at r.t., followed by the addi-
tion of PMBCl (65 mL, 0.5 mmol). The reaction mixture was stirred
at r.t. for 6 h and then quenched with H2O (5 mL). The mixture was
extracted with EtOAc (2 × 8 mL), the combined organic phases
were washed with brine (10 mL), dried over MgSO4, filtered, and
concentrated. The residue was purified by column chromatography
to give the pure product 9 as a yellow oil (55 mg, 63%).
IR (film): 2920, 2240, 1640, 1510, 1460, 1210 cm–1.
1H NMR (400 MHz, CD3OD): d = 7.25 (d, J = 8.6 Hz, 2 H), 6.89 (d,
J = 8.6 Hz, 2 H), 6.30 (s, 1 H), 4.58 (s, 2 H), 3.78 (s, 3 H), 3.36 (t,
J = 6.20 Hz, 2 H), 2.37 (t, J = 7.1 Hz, 2 H), 2.35 (t, J = 7.5 Hz, 2 H),
1.79 (m, 2 H), 1.55 (m, 2 H), 1.42–1.40 (m, 2 H), 1.34–1.31 (m, 6
H), 0.91 (t, J = 6.6 Hz, 3 H).
Synthesis 2006, No. 14, 2319–2322 © Thieme Stuttgart · New York